Absorption of high doses of cyclophosphamide given orally
Sohr, R.; Matthias, M.; Brockmann, B.; Preiss, R.
Die Pharmazie 38(6): 425-426
1983
ISSN/ISBN: 0031-7144 PMID: 6611644 Document Number: 201545
Document emailed within 1 workday
Related Documents
Fourtillan, J.B.; Lefebvre, M.A.; Saux, M.C.; Becq-Giraudon, B. 1980: Pharmacokinetic study of doxycycline in man by high performance liquid chromatography. Administration of single 200 mg doses intravenously and orally La Nouvelle Presse Medicale 9(21 Suppl): 77-81Emmerling, P.; Finger, H.; Henseling, M. 1973: The effect of high doses of antigen on cyclophosphamide-induced immunosuppression Arzneimittel-Forschung 23(1): 14-17
Kumar, S.; Gupta, R.K.; Bhake, A.S.; Samal, N. 1992: Cardiotoxic effects of high doses of cyclophosphamide in albino rats Archives Internationales de Pharmacodynamie et de Therapie 319: 58-65
Angelucci, E.; Polchi, P.; Lucarelli, G.; Galimberti, M.; Baronciani, D.; Giardini, C.; Durazzi, S.M.; Moretti, L.; Donati, M. 1989: Allogeneic bone marrow transplantation for hematological malignancies following therapy with high doses of busulphan and cyclophosphamide Haematologica 74(5): 455-461
Mulder, P.O.; Sleijfer, D.T.; Willemse, P.H.; de Vries, E.G.; Uges, D.R.; Mulder, N.H. 1989: High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumors Cancer Research 49(16): 4654-4658
Kantarjian, H.M.; Talpaz, M.; Andersson, B.; Khouri, I.; Giralt, S.; Rios, M.B.; Champlin, R.; Hester, J.; Deisseroth, A.B. 1994: High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia Bone Marrow Transplantation 14(1): 57-61
Nilsson, A.; Melin, T. 1988: Absorption and metabolism of orally fed arachidonic and linoleic acid in the rat American Journal of Physiology 255(5 Pt 1): G612-G618
Gladkikh, V.F.; Lebedeva, M.N. 1970: Study of absorption of phenasal administered orally to white rats Meditsinskaia Parazitologiia i Parazitarnye Bolezni 39(1): 88-91
Gerlóczy, A.; Fónagy, A.; Keresztes, P.; Perlaky, L.; Szejtli, J. 1985: Absorption, distribution, excretion and metabolism of orally administered 14C-beta-cyclodextrin in rat Arzneimittel-Forschung 35(7): 1042-1047
Nowicka, A.; Prussak, T.; Szukalski, B. 1975: Absorption, distribution in tissues and routes of excretion of preparation IF-ROM-196 administered to rats orally Materia Medica Polona. Polish Journal of Medicine and Pharmacy 7(4): 304-307
Kovacević, Z.; Mitrović, D.; Tomić, I.; Jovanović, D.; Skatarić, V.; Dimitrijević, J.; Rabrenović, V.; Trifunović, G. 1999: Pulsed doses of cyclophosphamide in the treatment of Wegener's granulomatosis Vojnosanitetski Pregled 56(1): 31-37
Gennari, C.; Vattimo, A.; Nardi, P. 1975: Effect of cyclophosphamide on intestinal absorption of radiophosphate in man Bollettino della Societa Italiana di Biologia Sperimentale 51(3): 90-92
Looney, W.B.; Ritenour, E.R.; Hopkins, H.A. 1980: Changes in growth rate of an experimental solid tumor following increasing doses of cyclophosphamide Cancer Research 40(7): 2179-2183
Rehulová, E. 1974: Changes in the urinary tract of dogs after toxic doses of the cytostatics cyclophosphamide and Cytembena Ceskoslovenska Patologie 10(4): 184-187
Kochnowski, G.; Rozek, G.; Wisńiewski, J. 1976: Early results of bronchogenic carcinoma treatment with massive doses of cyclophosphamide Wiadomosci Lekarskie 29(4): 270-271
Bezwoda, W.R.; Rastogi, R.B. 1994: A randomized comparative study of cyclophosphamide, vincristine, doxorubicin, and prednisolone and cyclophosphamide, vincristine, mitoxantrone, and prednisolone regimens in the treatment of intermediate- and high-grade lymphoma with 8 years' follow-up Seminars in Hematology 31(2 Suppl 3: 3
Oelshlegel, F.J.; Brewer, G.J. 1977: Absorption of pharmacologic doses of zinc Progress in Clinical and Biological Research 14: 299-316
Barth, J. 1979: Determination of minimal erythema doses by means of the UV high pressure mercury vapor lamp SL 500. I. Influence of sex, time point of reading and spectral distribution on the determination of the threshold doses Dermatologische Monatschrift 165(3): 216-219
Wilke, D. 2014: Is high-dose, orally administered alendronate analgesic? Medizinische Monatsschrift für Pharmazeuten 37(12): 459-460
Johnson, E.M.; Zimmerman, J.; Duderstadt, K.; Chambers, J.; Sorenson, A.L.; Granger, D.K.; Almond, P.S.; Fryer, J.p.; Leventhal, J.R.; Scarola, J.; Matas, A.J.; Canafax, D.M. 1996: A randomized, double-blind, placebo-controlled study of the safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients Transplantation Proceedings 28(2): 987